FindTrial
Sign In

Effects of giving local anaesthesia inside uterus for pain relief in patients undergoing dilation and curettage

Evaluation of Intrauterine 0.25% Levobupivacaine For Postoperative Analgesia In Patients Undergoing Dilation And Curettage: A Randomized Controlled Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113955
Enrollment
140
Registered
2026-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified Health Condition 2: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

Intervention1: 0.25 percent levobupivacaine: single dose of 5l 0.25 percent intrauterinelevobupivacaine intrauterine slowly over 1 minute Control Intervention1: normal saline: 5 ml normal saline

Sponsors

Ananta Institute of Medical Sciences and research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of abnormal uterine bledding scheduled for elective endometrial sampling. 2.ASA I and II

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women. 2.Drug allergy. 3.Cervical stenosis,unmarried females. 4.Patients who are unable to score their pain on the VAS.

Design outcomes

Primary

MeasureTime frame
Postoperative pain intensity measured by VAS.Timepoint: baseline 0 min 30 min 1 hr 2 hr 4 hr 6 hr 8 hr 12 hr 24 hr—

Secondary

MeasureTime frame
duration of analgesiaTimepoint: baseline 0 min 30 min 1 hr 2 hr 4 hr 6 hr 8 hr 12 hr 24 hr—

Countries

India

Contacts

Public ContactAnkita Kaasat

Ananta institute of medical sciences and research centre

ankitakaasat@gmail.com6361854732

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026